Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Stomach Disorders
When you encounter gastric polyp(s) on EGD, what characteristics prompt you to test for H. pylori?
Do you recommend testing all patients with gastric polyps for H. Pylori?
Related Questions
How do you approach continuing versus deprescribing long-term proton pump inhibitors in patients with severe corpus atrophy/GIM and numerous fundic gland polyps? Does the presence of advanced atrophy/GIM change your threshold to stop or step down therapy or switch class of acid-suppressive medication?
How do you approach H. pylori management in terms of evaluating or testing family members of patients who test positive?
What new or emerging therapies for autoimmune gastritis are available beyond iron and vitamin B12 replacement?
In a patient with Zieve's Syndrome and alcohol related cirrhosis which antibiotic regimen is safe to treat H. pylori?
How do you approach surveillance of gastric hyperplastic polyps of various sizes?
Is there evidence that certain PPIs provide superior clinical efficacy compared to others in real-world practice?
With the growth of non-alcoholic beverages (e.g., NA beer, liquor, etc), how do you approach a patient's consumption of these products in the setting of alcohol related liver disease?
When do you consider de-escalating therapy such as dupilumab in eosinophilic esophagitis?
In patients with MASLD, would you consider management with off-label metformin, pioglitazone (despite weight gain risk), GLP-1 RA, or simply intensify lifestyle and monitor?
How do you decide between anticoagulation and observation for an incidentally detected subsegmental pulmonary embolism in elderly patients with a history of gastrointestinal bleeding?